Current melanoma staging

Clinics in Dermatology

Volumn 22, Issue 3, 2004, Pages 223-227

  Petro, Anastasia ^a   Schwartz, Jennifer ^a   Johnson, Timothy ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; HUMAN; INFORMATION PROCESSING; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL ASSESSMENT; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN BIOPSY; SKIN ULCER; TUMOR LOCALIZATION;

EID: 3242710383     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.010     Document Type: Article

References (10)

1. American Cancer Society's 2003 Facts & Figures. URL: http://www.cancer.org/docroot/STT/stt_0.asp. Accessed June, 2003
2. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26
3. Balch C.M., Buzaid A.C., Soong S., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 19:2001;3635-3648
4. Balch C.M., Soong S., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 19:2001;3622-3634
5. Balch C.M., Buzaid A.C., Soong S.J., et al. New TNM mela-noma staging system linking biology and natural history to clinical outcomes. Semin Surg Oncol. 21:2003;43-52
6. Johnson TM, Bradford CR, Gruber SB, et al. Staging work-up, sentinel node biopsy and follow-up tests for melanoma: update of current concepts. Arch Dermatol. In press
7. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 17:1999;976-983
8. McMasters K.M., Reintgen D.S., Ross M.I., et al. Sentinel lymph node biopsy for melanoma controversy despite widespread agreement. J Clin Oncol. 19:2001;2851-2855
9. Azzola M.F., Shaw H.M., Thompson J.F., et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma an analysis of 3661 patients from a single center. Cancer. 97:2003;1488-1498
10. Bittner M., Meltzer P., Chen Y., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 406:2000;536-540